Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
9,990.00
-100.00 (-0.99%)
Dec 30, 2025, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 234.67 billion as of December 30, 2025. Its market cap has decreased by -16.82% in one year.
Market Cap
234.67B
Enterprise Value
196.62B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,990.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 234.67B, an increase of 46.45%. That is a compound annual growth rate of 7.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 232.34B | -3.12% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 767.46T |
| SK hynix | 413.58T |
| LG Energy Solution | 89.74T |
| Samsung Biologics | 78.32T |
| Hyundai Motor Company | 62.13T |
| Doosan Enerbility | 47.14T |
| Kia Corporation | 45.91T |
| HD Hyundai Heavy Industries | 45.45T |